Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-052781

Chief Medical Officer sold 25,000 shares at $50.00 ($1,250,000)

  • Chief Medical Officer acquired 25,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

BALDO LANCE · Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-09-29 Exercise or conversion : show line 1 in the form +25,000 $7.80 $195,000 25,000 D
2020-09-29 Sale : show line 2 in the form −25,000 $50.00 $1,250,000 0 D
Open-market sales · 25,000 sh · avg $50.00 · $1,250,000

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-09-29 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −25,000 400,000 D
Loading xslF345X03/doc4.xml…